JP2001524516A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001524516A5 JP2001524516A5 JP2000522905A JP2000522905A JP2001524516A5 JP 2001524516 A5 JP2001524516 A5 JP 2001524516A5 JP 2000522905 A JP2000522905 A JP 2000522905A JP 2000522905 A JP2000522905 A JP 2000522905A JP 2001524516 A5 JP2001524516 A5 JP 2001524516A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6702197P | 1997-12-01 | 1997-12-01 | |
| US6702097P | 1997-12-01 | 1997-12-01 | |
| US60/067,020 | 1997-12-01 | ||
| US60/067,021 | 1997-12-01 | ||
| US8484798P | 1998-05-08 | 1998-05-08 | |
| US60/084,847 | 1998-05-08 | ||
| US10739298P | 1998-11-06 | 1998-11-06 | |
| US60/107,392 | 1998-11-06 | ||
| PCT/CA1998/001093 WO1999027919A2 (en) | 1997-07-17 | 1998-12-01 | Cyp2a enzymes and their use in therapeutic and diagnostic methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001524516A JP2001524516A (ja) | 2001-12-04 |
| JP2001524516A5 true JP2001524516A5 (ja) | 2005-11-17 |
Family
ID=27490603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000522905A Pending JP2001524516A (ja) | 1997-12-01 | 1998-12-01 | Ｃｙｐ２ａ酵素に依存した治療及び診断方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1033979B2 (ja) |
| JP (1) | JP2001524516A (ja) |
| CN (1) | CN100362995C (ja) |
| AT (1) | ATE335484T1 (ja) |
| AU (1) | AU762671C (ja) |
| BR (1) | BR9815128A (ja) |
| CA (1) | CA2312851A1 (ja) |
| DE (1) | DE69835534T3 (ja) |
| ES (1) | ES2273441T5 (ja) |
| NZ (1) | NZ505439A (ja) |
| PT (1) | PT1033979E (ja) |
| WO (1) | WO1999027919A2 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9900490D0 (sv) * | 1999-02-15 | 1999-02-15 | A & Science Invest Ab | Diagnostic agent and method |
| GB9927806D0 (en) | 1999-11-24 | 2000-01-26 | Isis Innovation | Genetic indicators of tobacco consumption |
| US6492115B1 (en) * | 2000-06-02 | 2002-12-10 | Dna Sciences Laboratories, Inc. | Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods |
| US8688385B2 (en) * | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
| CN1308462C (zh) * | 2003-09-22 | 2007-04-04 | 周宏灏 | 个体化用药基因型诊断芯片及其制造方法和应用方法 |
| KR100829122B1 (ko) * | 2006-12-05 | 2008-05-13 | 한국과학기술연구원 | 당귀 추출물 또는 이로부터 분리한 쿠마린계 화합물을 유효성분으로 함유하는 폐암 예방용 조성물 |
| EP2031072A1 (en) * | 2007-08-27 | 2009-03-04 | Andreas Ziegler | Method for in-vitro diagnosing a predisposition to smoking and a pharmaceutical composition for treating tobacco abuse |
| JP5275060B2 (ja) * | 2009-01-30 | 2013-08-28 | 学校法人近畿大学 | Ｃｙｐ２ａ６阻害剤及びｃｙｐ２ａ６阻害活性物質のスクリーニング方法 |
| CN104004852B (zh) * | 2014-06-17 | 2015-12-02 | 陕西佰美基因股份有限公司 | 一种基于荧光定量pcr检测cyp2a6全基因缺失的方法 |
| EP3157519B1 (en) * | 2014-06-19 | 2021-05-12 | Immunolight, LLC | Methods and systems for treating cell proliferation disorders with psoralen derivatives |
| EP3207924A1 (de) | 2016-02-17 | 2017-08-23 | Flaxan GmbH & Co. KG | Pharmazeutische zubereitung zur hemmung humaner cyp-enzyme |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2066998C1 (ru) * | 1992-06-25 | 1996-09-27 | Валерий Иванович Вольвич | Способ получения средства для лечения вирусного гепатита а |
| AU2860295A (en) * | 1994-06-16 | 1996-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Defects in drug metabolism |
| DE19646977A1 (de) * | 1995-09-29 | 1998-01-15 | Schwabe Willmar Gmbh & Co | Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen |
| NZ334205A (en) † | 1996-07-17 | 2001-04-27 | Nicogen Inc | Method for regulating nicotine metabolism through inhibition of CYP2A6 and CYP2B6 liver enzymes |
-
1998
- 1998-12-01 PT PT98956735T patent/PT1033979E/pt unknown
- 1998-12-01 BR BR9815128-2A patent/BR9815128A/pt not_active Application Discontinuation
- 1998-12-01 WO PCT/CA1998/001093 patent/WO1999027919A2/en active IP Right Grant
- 1998-12-01 DE DE69835534T patent/DE69835534T3/de not_active Expired - Lifetime
- 1998-12-01 AT AT98956735T patent/ATE335484T1/de active
- 1998-12-01 EP EP98956735A patent/EP1033979B2/en not_active Expired - Lifetime
- 1998-12-01 ES ES98956735T patent/ES2273441T5/es not_active Expired - Lifetime
- 1998-12-01 CN CNB988131463A patent/CN100362995C/zh not_active Expired - Fee Related
- 1998-12-01 AU AU13286/99A patent/AU762671C/en not_active Ceased
- 1998-12-01 NZ NZ505439A patent/NZ505439A/en unknown
- 1998-12-01 JP JP2000522905A patent/JP2001524516A/ja active Pending
- 1998-12-01 CA CA002312851A patent/CA2312851A1/en not_active Abandoned